Cited by 67Cytokine Signaling Pathways and InteractionsReceptor Mechanisms and SignalingCardiac electrophysiology and arrhythmias

Critical roles of STAT3 in β-adrenergic functions in the heart

Open access
Zhang, Wenjun, Qu, Xiuxia, Chen, Biyi, Snyder, Marylynn, Wang, Meijing, Li, Baiyan, Tang, Yue, Chen, Hanying +12 more·2016·Circulation

Abstract

Background—: β-Adrenergic receptors (βARs) play paradoxical roles in the heart. On one hand, βARs augment cardiac performance to fulfill the physiological demands, but on the other hand, prolonged activations of βARs exert deleterious effects that result in heart failure. The signal transducer and activator of transcription 3 (STAT3) plays a dynamic role in integrating multiple cytokine signaling pathways in a number of tissues. Altered activation of STAT3 has been observed in failing hearts in both human patients and animal models. Our objective is to determine the potential regulatory roles of STAT3 in cardiac βAR-mediated signaling and function. Methods and Results—: We observed that STAT3 can be directly activated in cardiomyocytes by β-adrenergic agonists. To follow up this finding, we analyzed βAR function in cardiomyocyte-restricted STAT3 knockouts and discovered that the conditional loss of STAT3 in cardiomyocytes markedly reduced the cardiac contractile response to acute βAR stimulation, and caused disengagement of calcium coupling and muscle contraction. Under chronic β-adrenergic stimulation, Stat3cKO hearts exhibited pronounced cardiomyocyte hypertrophy, cell death, and subsequent cardiac fibrosis. Biochemical and genetic data supported that Gα s and Src kinases are required for βAR-mediated activation of STAT3. Finally, we demonstrated that STAT3 transcriptionally regulates several key components of βAR pathway, including β 1 AR, protein kinase A, and T-type Ca 2+ channels. Conclusions—: Our data demonstrate for the first time that STAT3 has a fundamental role in βAR signaling and functions in the heart. STAT3 serves as a critical transcriptional regulator for βAR-mediated cardiac stress adaption, pathological remodeling, and heart failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.017472

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-6 treatment reduces endothelial disruption and neutrophil sequestration in lung and alveolar spaces, resulting in improved oxygenation after I/R.

    “IL-6 treatment also reduced endothelial disruption and neutrophil sequestration in lung and alveolar spaces, resulting in improved oxygenation after I/R (Zhang et al., 2016).”

    From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Zhang et al., 2016

    The Results section on β-adrenergic STAT3 activation mentions an IL-6-family cytokine only as a laboratory positive control. The Results on chronic β-adrenergic stimulation concern cardiac injury, not lung injury. Searches for neutrophil sequestration, endothelial disruption, oxygenation, and lung ischemia/reperfusion found no passage addressing the attributed claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 47

  1. [1]Lefkowitz RJ Rockman HA Koch WJ Catecholamines, cardiac beta-adrenergic receptors, and heart failure Circulation 2000 101 1634 7 10758041
  2. [2]Rockman HA Koch WJ Lefkowitz RJ Seven-transmembrane-spanning receptors and heart function Nature 2002 415 206 12 11805844
  3. [3]Bristow MR Ginsburg R Umans V Fowler M Minobe W Rasmussen R Zera P Menlove R Shah P Jamieson S Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Circ Res 1986 59 297 309 2876788
  4. [4]Koch WJ Lefkowitz RJ Rockman HA Functional consequences of altering myocardial adrenergic receptor signaling Annu Rev Physiol 2000 62 237 60 10845091
  5. [5]Lohse MJ Engelhardt S Eschenhagen T What is the role of beta-adrenergic signaling in heart failure? Circ Res 2003 93 896 906 14615493
  6. [6]Zhu WZ Wang SQ Chakir K Yang D Zhang T Brown JH Devic E Kobilka BK Cheng H Xiao RP Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II J Clin Invest 2003 111 617 25 12618516 PMC151893
  7. [7]Singh K Communal C Sawyer DB Colucci WS Adrenergic regulation of myocardial apoptosis Cardiovasc Res 2000 45 713 9 10728393
  8. [8]Luttrell LM Ferguson SS Daaka Y Miller WE Maudsley S Della Rocca GJ Lin F Kawakatsu H Owada K Luttrell DK Caron MG Lefkowitz RJ Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes Science 1999 283 655 61 9924018
  9. [9]Lavoie C Mercier JF Salahpour A Umapathy D Breit A Villeneuve LR Zhu WZ Xiao RP Lakatta EG Bouvier M Hebert TE Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy J Biol Chem 2002 277 35402 10 12140284
  10. [10]Ma YC Huang J Ali S Lowry W Huang XY Src tyrosine kinase is a novel direct effector of G proteins Cell 2000 102 635 46 11007482
  11. [11]Noma T Lemaire A Naga Prasad SV Barki-Harrington L Tilley DG Chen J Le Corvoisier P Violin JD Wei H Lefkowitz RJ Rockman HA Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection J Clin Invest 2007 117 2445 58 17786238 PMC1952636
  12. [12]Kim IM Tilley DG Chen J Salazar NC Whalen EJ Violin JD Rockman HA Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation Proc Natl Acad Sci U S A 2008 105 14555 60 18787115 PMC2567217
  13. [13]Bromberg JF Darnell JE Jr Potential roles of Stat1 and Stat3 in cellular transformation Cold Spring Harb Symp Quant Biol 1999 64 425 8 11232317
  14. [14]Levy DE Lee CK What does Stat3 do? J Clin Invest 2002 109 1143 8 11994402 PMC150972
  15. [15]Stark GR Darnell JE Jr The JAK-STAT pathway at twenty Immunity 2012 36 503 14 22520844 PMC3909993
  16. [16]Fischer P Hilfiker-Kleiner D Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis Basic Res Cardiol 2007 102 279 97 17530315
  17. [17]Ng DC Court NW dos Remedios CG Bogoyevitch MA Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts Cardiovasc Res 2003 57 333 46 12566106
  18. [18]Tsoutsman T Kelly M Ng DC Tan JE Tu E Lam L Bogoyevitch MA Seidman CE Seidman JG Semsarian C Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy Circulation 2008 117 1820 31 18362229
  19. [19]Jacoby JJ Kalinowski A Liu MG Zhang SS Gao Q Chai GX Ji L Iwamoto Y Li E Schneider M Russell KS Fu XY Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age Proc Natl Acad Sci U S A 2003 100 12929 34 14566054 PMC240721
  20. [20]Hilfiker-Kleiner D Hilfiker A Fuchs M Kaminski K Schaefer A Schieffer B Hillmer A Schmiedl A Ding Z Podewski E Podewski E Poli V Schneider MD Schulz R Park JK Wollert KC Drexler H Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury Circ Res 2004 95 187 95 15192020
  21. [21]Wu B Zhou B Wang Y Cheng HL Hang CT Pu WT Chang CP Zhou B Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse Genesis 2010 48 63 72 20014345 PMC2806493
  22. [22]Hang CT Yang J Han P Cheng HL Shang C Ashley E Zhou B Chang CP Chromatin regulation by Brg1 underlies heart muscle development and disease Nature 2010 466 62 7 20596014 PMC2898892
  23. [23]Kim KK Soonpaa MH Daud AI Koh GY Kim JS Field LJ Tumor suppressor gene expression during normal and pathologic myocardial growth J Biol Chem 1994 269 22607 13 8077211
  24. [24]Chen H Yong W Ren S Shen W He Y Cox KA Zhu W Li W Soonpaa M Payne RM Franco D Field LJ Rosen V Wang Y Shou W Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth J Biol Chem 2006 281 27481 91 16798733 PMC2628764
  25. [25]Huang C Gu H Zhang W Manukyan MC Shou W Wang M SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury Am J Physiol Heart Circ Physiol 2011 301 H1496 505 21821779 PMC3197365
  26. [26]Wang M Zhang W Crisostomo P Markel T Meldrum KK Fu XY Meldrum DR Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling Am J Physiol Heart Circ Physiol 2007 293 H2101 8 17675575
  27. [27]Bastepe M Gunes Y Perez-Villamil B Hunzelman J Weinstein LS Juppner H Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit Mol Endocrinol 2002 16 1912 9 12145344
  28. [28]Sun Y Huang J Xiang Y Bastepe M Juppner H Kobilka BK Zhang JJ Huang XY Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR EMBO J 2007 26 53 64 17170700 PMC1782364
  29. [29]Sulakhe PV Vo XT Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization Mol Cell Biochem 1995 149–150 103 26 8569720
  30. [30]Chen X Xu H Yuan P Fang F Huss M Vega VB Wong E Orlov YL Zhang W Jiang J Loh YH Yeo HC Yeo ZX Narang V Govindarajan KR Leong B Shahab A Ruan Y Bourque G Sung WK Clarke ND Wei CL Ng HH Integration of external signaling pathways with the core transcriptional network in embryonic stem cells Cell 2008 133 1106 17 18555785
  31. [31]Kidder BL Yang J Palmer S Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells PLoS One 2008 3 e3932 19079543 PMC2592696
  32. [32]Martinez ML Heredia MP Delgado C Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts J Mol Cell Cardiol 1999 31 1617 25 10471346
  33. [33]Kinoshita H Kuwahara K Takano M Arai Y Kuwabara Y Yasuno S Nakagawa Y Nakanishi M Harada M Fujiwara M Murakami M Ueshima K Nakao K T-type Ca2+ channel blockade prevents sudden death in mice with heart failure Circulation 2009 120 743 52 19687356
  34. [34]Montgomery RL Davis CA Potthoff MJ Haberland M Fielitz J Qi X Hill JA Richardson JA Olson EN Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility Genes Dev 2007 21 1790 802 17639084 PMC1920173
  35. [35]Chiang CS Huang CH Chieng H Chang YT Chang D Chen JJ Chen YC Chen YH Shin HS Campbell KP Chen CC The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice Circ Res 2009 104 522 30 19122177
  36. [36]Nuss HB Houser SR T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes Circ Res 1993 73 777 82 8396509
  37. [37]Yin F Li P Zheng M Chen L Xu Q Chen K Wang YY Zhang YY Han C Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart J Biol Chem 2003 278 21070 5 12665506
  38. [38]Szabo-Fresnais N Lefebvre F Germain A Fischmeister R Pomerance M A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling Cell Signal 2010 22 1143 52 20227492
  39. [39]Cambi GE Lucchese G Djeokeng MM Modesti A Fiaschi T Faggian G Sani G Modesti PA Impaired JAK2-induced activation of STAT3 in failing human myocytes Mol Biosyst 2012 8 2351 9 22735740
  40. [40]Kuwahara K Saito Y Takano M Arai Y Yasuno S Nakagawa Y Takahashi N Adachi Y Takemura G Horie M Miyamoto Y Morisaki T Kuratomi S Noma A Fujiwara H Yoshimasa Y Kinoshita H Kawakami R Kishimoto I Nakanishi M Usami S Saito Y Harada M Nakao K NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function EMBO J 2003 22 6310 21 14633990 PMC291842
  41. [41]Tanaka H Shigenobu K Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels Cardiovasc Drug Rev 2002 20 81 92 12070536
  42. [42]Jenkins BJ Grail D Nheu T Najdovska M Wang B Waring P Inglese M McLoughlin RM Jones SA Topley N Baumann H Judd LM Giraud AS Boussioutas A Zhu HJ Ernst M Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling Nat Med 2005 11 845 52 16041381
  43. [43]Hilfiker-Kleiner D Kaminski K Podewski E Bonda T Schaefer A Sliwa K Forster O Quint A Landmesser U Doerries C Luchtefeld M Poli V Schneider MD Balligand JL Desjardins F Ansari A Struman I Nguyen NQ Zschemisch NH Klein G Heusch G Schulz R Hilfiker A Drexler H A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy Cell 2007 128 589 600 17289576
  44. [44]Bristow MR Ginsburg R Minobe W Cubicciotti RS Sageman WS Lurie K Billingham ME Harrison DC Stinson EB Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N Engl J Med 1982 307 205 11 6283349
  45. [45]Brodde OE Vogelsang M Broede A Michel-Reher M Beisenbusch-Schafer E Hakim K Zerkowski HR Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy J Cardiovasc Pharmacol 1998 31 585 94 9554809
  46. [46]Podewski EK Hilfiker-Kleiner D Hilfiker A Morawietz H Lichtenberg A Wollert KC Drexler H Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy Circulation 2003 107 798 802 12591746
  47. [47]Tsoutsman T Bagnall RD Semsarian C Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure Clin Exp Pharmacol Physiol 2008 35 1349 57 18761664

Cited by

Sorted by citations

Authors
Zhang, W., Qu, X., Chen, B., Snyder, M., Wang, M., Li, B., Tang, Y., Chen, H., Zhu, W., Zhan, L., Yin, N., Li, D., Xie, L., Liu, Y., Zhang, J. J., Fu, X.-Y., Rubart, M., Song, L.-S., Huang, X.-Y., & Shou, W.
Affiliations
  • University of Iowa (US)
  • From State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (W. Zhang, X.Q., Y.T., W.S.); Riley Heart Research Center, Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indianapolis, IN (W. Zhang, B.L., H.C., W. Zhu, L.Z., N.Y., D.L., L.X., Y.L., M.R., W.S.); Department of Internal Medicine, Carver College of Medicine, University of Iowa,...
Venue
Circulation
Published
2016-01-05
Volume
133
Issue
1
Pages
48-61
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2183417521
Cited by
67
References
0
Citations by year
2026: 5 · 2025: 3 · 2024: 7 · 2023: 10 · 2022: 3 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 1
FWCI
1.60
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (U01AA023503, R01AA023503)
  • National Heart, Lung, and Blood Institute (R01HL090905, R01HL081092, HL 91525, HL090905, R01HL130346, R01HL091525, HL81092)
  • National Cancer Institute (CA125568-05, R01CA125568)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
STAT3, beta-adrenergic receptors, heart failure, cardiomyocytes, cardiac contractility, cardiomyocyte hypertrophy, myocardial fibrosis, Gs protein, Src kinase, protein kinase A, T-type calcium channels, beta1-adrenergic receptor, transcriptional regulation, cardiac remodeling
MeSH terms
Adrenergic beta-Agonists, Animals, Cell Line, Heart, Male, Mice, Inbred C57BL, Organ Culture Techniques, Receptors, Adrenergic, beta, Mice, Knockout, Myocytes, Cardiac, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review